Literature DB >> 35061812

Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.

.   

Abstract

Entities:  

Year:  2022        PMID: 35061812      PMCID: PMC8782327          DOI: 10.1371/journal.pone.0263037

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
After this article was published, similarities were noted between this article and submissions by other research groups which call into question the validity and provenance of the reported results and the adherence of this article to the PLOS Authorship policy. The authors provided data files to support the article’s results, but the comments and files received did not resolve the concerns. In discussing this matter, the corresponding author requested the article’s retraction. In light of the above issues, the PLOS ONE Editors retract this article [1]. JC agreed with retraction. TT, QY, CZ, and XL did not respond or could not be reached.
  1 in total

1.  MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.

Authors:  Tingke Tian; Quanzhong Yang; Cuijuan Zhang; Xiaokun Li; Jiancheng Cheng
Journal:  PLoS One       Date:  2021-05-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.